FR2448903A1 - Fast acting antimicrobial compsns. - contg. antimicrobial, enzyme, antiinflammatory, and opt. local anaesthetic, keratolytic, mucolytic and emulsifier - Google Patents

Fast acting antimicrobial compsns. - contg. antimicrobial, enzyme, antiinflammatory, and opt. local anaesthetic, keratolytic, mucolytic and emulsifier

Info

Publication number
FR2448903A1
FR2448903A1 FR7904162A FR7904162A FR2448903A1 FR 2448903 A1 FR2448903 A1 FR 2448903A1 FR 7904162 A FR7904162 A FR 7904162A FR 7904162 A FR7904162 A FR 7904162A FR 2448903 A1 FR2448903 A1 FR 2448903A1
Authority
FR
France
Prior art keywords
opt
antimicrobial
agent
enzyme
mucolytic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7904162A
Other languages
French (fr)
Other versions
FR2448903B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR7904162A priority Critical patent/FR2448903A1/en
Publication of FR2448903A1 publication Critical patent/FR2448903A1/en
Application granted granted Critical
Publication of FR2448903B1 publication Critical patent/FR2448903B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01035—Hyaluronoglucosaminidase (3.2.1.35), i.e. hyaluronidase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Medicaments contg. (a) an antimicrobial agent, (b) an enzyme, (c) an anti-inflammatory, (d) opt. a local anaesthetic, (e) opt. a keratolylic agent, (f) opt. a mucolytic agent, and (g) opt. an emulsifying agnet, are new. Antimicrobials for use in dermatology, oto-rhinolaryngology and pneumology are rapid acting. (a) is typically an aminoglycoside, a penicillin, a cephalosporin. The enzyme (b) is pref. hyalouronidase, streptokinase, streptodonase, etc., (c) may be a natural or synthetic corticoid. Suitable local anaesthetics (d) include procaine, while the keratolytic agent (e) may be tretinoine, salicylic acid, or resorcinol benzoic acid. The mucolytic agent (f) is generally cysteine, and the emulsifying agent (f) is generally cysteine, and the emulsifying agent (g) may be polysorbate, sorbitan, or sodium lauryl sulphate.
FR7904162A 1979-02-19 1979-02-19 Fast acting antimicrobial compsns. - contg. antimicrobial, enzyme, antiinflammatory, and opt. local anaesthetic, keratolytic, mucolytic and emulsifier Granted FR2448903A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7904162A FR2448903A1 (en) 1979-02-19 1979-02-19 Fast acting antimicrobial compsns. - contg. antimicrobial, enzyme, antiinflammatory, and opt. local anaesthetic, keratolytic, mucolytic and emulsifier

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7904162A FR2448903A1 (en) 1979-02-19 1979-02-19 Fast acting antimicrobial compsns. - contg. antimicrobial, enzyme, antiinflammatory, and opt. local anaesthetic, keratolytic, mucolytic and emulsifier

Publications (2)

Publication Number Publication Date
FR2448903A1 true FR2448903A1 (en) 1980-09-12
FR2448903B1 FR2448903B1 (en) 1982-10-08

Family

ID=9222144

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7904162A Granted FR2448903A1 (en) 1979-02-19 1979-02-19 Fast acting antimicrobial compsns. - contg. antimicrobial, enzyme, antiinflammatory, and opt. local anaesthetic, keratolytic, mucolytic and emulsifier

Country Status (1)

Country Link
FR (1) FR2448903A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0072947A2 (en) * 1981-08-10 1983-03-02 Kaken Pharmaceutical Co., Ltd. Agent for the prevention and treatment of liver diseases
FR2618072A1 (en) * 1987-07-17 1989-01-20 Oreal PHARMACEUTICAL AND COSMETIC COMPOSITIONS BASED ON PYRIDONES AND ANTIBACTERIAL AGENTS
WO2000038732A1 (en) * 1998-12-23 2000-07-06 Esparma Gmbh Hyaluronate lyase used for promoting penetration in topical agents
WO2001060399A1 (en) * 2000-02-21 2001-08-23 Topic Empreendimentos E Participações S/C Ltda. Diclofenac pharmaceutical composition based on vitamin-e, papain and hyaluronidase
US6689349B1 (en) 1998-12-23 2004-02-10 Esparma Gmbh Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis
US20140073604A1 (en) * 2010-09-29 2014-03-13 University Of North Carolina At Wilmington Ladder-Frame Polyether Conjugates
WO2017019943A1 (en) * 2015-07-29 2017-02-02 Susanne Gardner Antimicrobial formulations and applications thereof
US10682360B2 (en) 2014-01-27 2020-06-16 Susanne GARDNER Antimicrobial formulations and applications thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2036M (en) * 1962-08-02 1963-09-23 Sobio Lab Anti-infectious and anti-inflammatory therapeutic compositions.
FR3483M (en) * 1963-08-01 1965-08-16 Pluripharm
GB1049104A (en) * 1963-05-11 1966-11-23 Prodotti Antibiotici Spa Pharmaceutical compositions for oral or parenteral administration comprising tetracycline antibiotics
FR2279421A1 (en) * 1974-04-29 1976-02-20 Sutures Inc APPLICATION OF PROTEOLYTIC ENZYMES AS AN AUXILIARY FOR ANTIBIOTIC PROPHYLAXIS OF CONTAMINATED INJURIES
DE2617876A1 (en) * 1975-05-14 1976-11-25 Parcor PHARMACEUTICAL PRODUCTS WITH ANTIBACTERIAL EFFECT

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2036M (en) * 1962-08-02 1963-09-23 Sobio Lab Anti-infectious and anti-inflammatory therapeutic compositions.
GB1049104A (en) * 1963-05-11 1966-11-23 Prodotti Antibiotici Spa Pharmaceutical compositions for oral or parenteral administration comprising tetracycline antibiotics
FR3483M (en) * 1963-08-01 1965-08-16 Pluripharm
FR2279421A1 (en) * 1974-04-29 1976-02-20 Sutures Inc APPLICATION OF PROTEOLYTIC ENZYMES AS AN AUXILIARY FOR ANTIBIOTIC PROPHYLAXIS OF CONTAMINATED INJURIES
DE2617876A1 (en) * 1975-05-14 1976-11-25 Parcor PHARMACEUTICAL PRODUCTS WITH ANTIBACTERIAL EFFECT

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
EXBK/61 *

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0072947A2 (en) * 1981-08-10 1983-03-02 Kaken Pharmaceutical Co., Ltd. Agent for the prevention and treatment of liver diseases
EP0072947A3 (en) * 1981-08-10 1983-07-27 Kaken Chemical Company, Ltd. Agent for the prevention and treatment of liver and kidney diseases
FR2618072A1 (en) * 1987-07-17 1989-01-20 Oreal PHARMACEUTICAL AND COSMETIC COMPOSITIONS BASED ON PYRIDONES AND ANTIBACTERIAL AGENTS
BE1002690A4 (en) * 1987-07-17 1991-05-07 Oreal PHARMACEUTICAL AND COSMETIC COMPOSITIONS BASED ON PYRIDONES AND ANTIBACTERIAL AGENTS.
WO2000038732A1 (en) * 1998-12-23 2000-07-06 Esparma Gmbh Hyaluronate lyase used for promoting penetration in topical agents
US6689349B1 (en) 1998-12-23 2004-02-10 Esparma Gmbh Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis
US6719986B1 (en) 1998-12-23 2004-04-13 Esparma Gmbh Hyaluronate lyase used for promoting penetration in topical agents
WO2001060399A1 (en) * 2000-02-21 2001-08-23 Topic Empreendimentos E Participações S/C Ltda. Diclofenac pharmaceutical composition based on vitamin-e, papain and hyaluronidase
US20140073604A1 (en) * 2010-09-29 2014-03-13 University Of North Carolina At Wilmington Ladder-Frame Polyether Conjugates
US10682360B2 (en) 2014-01-27 2020-06-16 Susanne GARDNER Antimicrobial formulations and applications thereof
WO2017019943A1 (en) * 2015-07-29 2017-02-02 Susanne Gardner Antimicrobial formulations and applications thereof

Also Published As

Publication number Publication date
FR2448903B1 (en) 1982-10-08

Similar Documents

Publication Publication Date Title
DK0659440T3 (en) Calcium-modified, oxidized cellulose hemostat
DK76085A (en) ANTI-INFLAMMATORY RELATIONS AND PHARMACEUTICAL AGENTS CONTAINING RELATIONSHIPS
AR245369A1 (en) New medicaments for topical use
AU512371B2 (en) Topical antiinflammatory treatment ofthe skin and composition therefore
PT92131A (en) PROCESS FOR THE PREPARATION OF MEDIA FOR TRANSDERMIC APPLICATION OF GESTODENO
ATE141251T1 (en) 4-DEMETHOXY-4-AMINO-ANTHRACYCLINE
ES546840A0 (en) A PROCEDURE FOR PREPARING A SALT OF N-ACETYL- NEURAMINIC ACID
FR2448903A1 (en) Fast acting antimicrobial compsns. - contg. antimicrobial, enzyme, antiinflammatory, and opt. local anaesthetic, keratolytic, mucolytic and emulsifier
FR2357246A1 (en) Antiinflammatory and analgesic medicaments - contg. hydrolase, thyroxine and adrenalin and applied topically
AU2828484A (en) Pharmaceutical composition for the treatment of hair loss
ES2078256T3 (en) PHARMACEUTICAL FORMULA FOR TOPICAL USE CONTAINING SODIUM DICLOFENACO.
ES486749A1 (en) Isoxazole derivatives, process for their preparation, medicines containing them and intermediates required in this process.
ES2032476T3 (en) A PROCEDURE FOR PREPARING NEW 2-ANILINOTIAZOLINE DERIVATIVES.
SU627047A1 (en) Device for winding long-size material
AU3764689A (en) Use of local anaesthetic agents in the manufacture of preparations with wound healing effect
FR2358145A1 (en) Pharmaceutical compsns. contg. para-acetamido-phenol deriv. - i.e. the (1)-para-chlorobenzoyl-(2)-methyl-(5)-methoxy-indole-(3)-acetate, having antiinflammatory, analgesic, and antipyretic activity
JPS5211023A (en) Casset tape winding unit
JPS56125312A (en) Remedy for damage
ES404928A1 (en) 2-(3{40 -trifluoromethylthio-anilino)-benzoic acid and salts thereof with pharmaceutically acceptable bases
FR2379511A1 (en) Analgesic and antiinflammatory lysine salt - of alpha-methyl-2-isopropyl-5-indanyl-acetic acid
JPS5397404A (en) Endless tape
JPS5230130A (en) Store control system of multihierarchy memory
JPS5615208A (en) Remedy for trichophytosis
IT1197933B (en) New topical antiinflammatory compsn.
JPS5379856A (en) Preparation of optical active 1-methyl-2-(beta-hydroxyethyl)pyrrplidive

Legal Events

Date Code Title Description
CL Concession to grant licences
CL Concession to grant licences
ST Notification of lapse